JINS HOLDINGS Inc. (TYO:3046)
Japan · Delayed Price · Currency is JPY 5,580.00
-120.00 (-2.11%)
Dec 10, 2025, 11:30 AM JST
JINS HOLDINGS Revenue
In the fiscal year ending August 31, 2025, JINS HOLDINGS had annual revenue of 97.22B JPY with 17.13% growth. JINS HOLDINGS had revenue of 27.40B in the quarter ending August 31, 2025, with 14.95% growth.
Revenue
97.22B
Revenue Growth
+17.13%
P/S Ratio
1.37
Revenue / Employee
26.48M
Employees
3,485
Market Cap
133.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 97.22B | 14.22B | 17.13% |
| Aug 31, 2024 | 83.00B | 9.74B | 13.29% |
| Aug 31, 2023 | 73.26B | 6.36B | 9.51% |
| Aug 31, 2022 | 66.90B | 3.00B | 4.70% |
| Aug 31, 2021 | 63.90B | 3.64B | 6.04% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |